Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Ginah Nightingale, PharmD, BCOP, of Thomas Jefferson University, Philadelphia, PA, discusses the importance of identifying chemotherapy drugs that cause cognitive impairment, and ensuring that physicians are aware of and can deal with these conditions. Dr Nightingale then speaks about the different types of patients that should be screened for cognitive impairment and what role pharmacists play in this testing.

свернуть